tiprankstipranks

Robert Blum Insider Profile

11 Followers
Robert Blum, President & CEO, Director at Cytokinetics, holds 401.62K shares in Cytokinetics (Ticker: CYTK), holds 96.50K shares in Gamida Cell (Ticker: GMDAQ).
tipranks
Robert Blum

Robert Blum
Cytokinetics (CYTK)
President & CEO, Director

Ranked #92,740 out of 99,635 Corporate Insiders

Profitable Transactions

50%
12 out of 24 Profitable Transactions

Average Return

-21.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20M
100.00%
A breakdown of Robert Blum's holdings

Insider Roles

Cytokinetics
(CYTK)
President & CEO, Director
Roles that Robert Blum holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Jul 31, 2024 - Today
Return:+16.70%
The most profitable trade made by Robert Blum

Robert Blum's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cytokinetics
Nov 19, 2024
President & CEO, Director
Uninformative Buy
33.35K
$19.72M
GMDAQ
Gamida Cell
Feb 10, 2023
Uninformative Buy
$1.54K
List of latest transactions for each holding click on a transaction to see Robert Blum's performance on stock

Robert Blum insider profile FAQ

What is the percentage of profitable transactions made by Robert Blum?
The percentage of profitable transactions made by Robert Blum is 50%.
    What is the average return per transaction made by Robert Blum?
    The average return per transaction made by Robert Blum is -21.20%.
      What stocks does Robert Blum hold?
      Robert Blum holds: CYTK, GMDAQ stocks.
        What was Robert Blum’s latest transaction?
        Robert Blum latest transaction was an Uninformative Buy of $33.35K.
          What was Robert Blum's most profitable transaction?
          Robert Blum’s most profitable transaction was an Informative Sell of CYTK stock on July 31, 2024. The return on the trade was 16.70%.
            What is Robert Blum's role in Cytokinetics?
            Robert Blum's role in Cytokinetics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.